+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation"

From
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
From
Disease Analysis: Crohn's Disease - Product Thumbnail Image

Disease Analysis: Crohn's Disease

  • Report
  • June 2021
  • 75 Pages
  • Global
Disease Analysis: Multiple Sclerosis - Product Thumbnail Image

Disease Analysis: Multiple Sclerosis

  • Report
  • May 2021
  • 82 Pages
  • Global
Disease Analysis: Ulcerative Colitis - Product Thumbnail Image

Disease Analysis: Ulcerative Colitis

  • Report
  • May 2021
  • 103 Pages
  • Global
Market Spotlight: Gout - Product Thumbnail Image

Market Spotlight: Gout

  • Report
  • January 2021
  • 38 Pages
  • Global
Crohn's Disease Forecast and Market Analysis to 2026 - Product Thumbnail Image

Crohn's Disease Forecast and Market Analysis to 2026

  • Report
  • August 2018
  • 679 Pages
  • Global
From
Axial Spondyloarthritis: Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Forecast in Asia-Pacific Markets to 2028

  • Report
  • February 2020
  • 150 Pages
  • Asia Pacific
From
Loading Indicator

The Inflammation market within the context of Allergy and Immunology is a rapidly growing field of research and development. It focuses on the study of the body's immune system and its response to allergens, pathogens, and other foreign substances. This includes the development of treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. The market is driven by the increasing prevalence of allergies and autoimmune diseases, as well as the need for more effective treatments. The Inflammation market is composed of a variety of companies, ranging from pharmaceuticals to biotechnology firms. These companies are focused on developing new treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. Examples of companies in this market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more